The Biotech Investor's Bible

Wolff, George

ISBN 10: 0471412791 ISBN 13: 9780471412793
Verlag: Wiley, 2001
Gebraucht Hardcover

Verkäufer WeBuyBooks, Rossendale, LANCS, Vereinigtes Königreich Verkäuferbewertung 5 von 5 Sternen 5 Sterne, Erfahren Sie mehr über Verkäufer-Bewertungen

AbeBooks-Verkäufer seit 14. November 2005


Beschreibung

Beschreibung:

Most items will be dispatched the same or the next working day. A copy that has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged. Bestandsnummer des Verkäufers wbs1419272391

Diesen Artikel melden

Inhaltsangabe:

A one-stop source for investing in biotech-with detailed coverage of the science, the business, the players, and the strategies for one of today's most promising (and volatile) industries

To invest in biotech is to invest in the future, and as such, investors need to learn the nuances of the science they're putting their money on. The core asset of biotech companies is knowledge, and sound investment decisions are impossible without an understanding of this complex science. That's where The Biotech Investor's Bible fits in. This much-needed, one-of-a-kind resource simplifies the complex science surrounding the business of biotech and clarifies subtle distinctions within the context of their financial repercussions. The book explains the basics of genetics, patents, and therapies; and teaches investors how to value biotech companies and their state-of-the art products and technology. The Biotech Investor's Bible offers an informative summary of the relatively short history of the industry and provides a comprehensive review of various industry sectors.

Über die Autorin bzw. den Autor:

GEORGE WOLFF is an award-winning journalist and, currently, a private business consultant to several firms in the investment industry. He has assessed and reported on more than 200 biotechnology companies for his clientele, issuing a number of valuable white papers charting the emergence of biotechnology. Previously, as a journalist, Wolff worked internationally covering the onset of the AIDS epidemic, the emergence of recombinant DNA technology, and the extraordinary stock market events of the previous twenty years. Wolff can be contacted through his web site, BioWolff.com.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Bibliografische Details

Titel: The Biotech Investor's Bible
Verlag: Wiley
Erscheinungsdatum: 2001
Einband: Hardcover
Zustand: Very Good

Beste Suchergebnisse beim ZVAB

Es gibt 10 weitere Exemplare dieses Buches

Alle Suchergebnisse ansehen